Issue #2 2016 – Digital edition

• FOREWORD: New regulatory strategies to address unmet clinical needs
  David Elder, GlaxoSmithKline and JPAG
• REGULATORY INSIGHT: CEIV Pharma – Industry cooperation that is taking off
  Ricardo Aitken and Michal Wielgus, IATA Consulting
• ONCOLOGY: Inhibition of mutant P53 tumour cells by medicinal plants
  Osuntokun Oludare Temitope and Ogunleye Adewale Joseph, Adekunle Ajasin University
• IN-DEPTH FOCUS: SINGLE USE
  With articles from Laura Holtmann and Martin Lobedann, Invite GmbH, Jorgen Magnus, Bayer, Gerhard Schembecker, TU Dortmund University, Akiko Ishii-Watabe and Akihiko Hirose, National Institute of Health Sciences, Sei Murakami, Hitachi, Takehiro Okumura, Takeda Pharmaceutical, Hiroyuki Matsuda, Fujimori Kogyo and Daisuke Kajihara, GE Healthcare Japan Corporation
• ROBOTICS: New trends in intelligent robotics in the laboratory
  Dr. Patrick Courtney, tec-connection
• MICROBIOLOGY SERIES: Novel approach in assessing the antimicrobial efficacy of eye drop products
  Mostafa Eissa, Hikma Pharmaceuticals
• PAT SERIES: Exploring the advantages of PAT for pharmaceutical cleaning in Ireland
  Adeyinka Aina, University of Nottingham, Manuel Kuhs, Bernal Powder Engineering Research Group, Shaza Darwish, University of Limerick and Dr Chris Edlin, Pharmaceutical Technology Manufacturing Centre
• IN-DEPTH FOCUS: MASS SPECTROMETRY
  Featuring contributions from Pilsoo Kang and Jianmei Kochling, Sanofi, Hanjo Lim, Genentech and Rick A. Davies, Melanie Snow, Jonathan Renshaw, AstraZeneca
• DRUG DELIVERY: Stem cell nano drug delivery applications to treat diabetes
  Vishal Shahidadpury, Anjali Hirani and Yashwant Pathak, University of South Florida Health
• NANOTECHNOLOGY: Nanotechnology tackles problems with noninvasive glucose monitoring
  Andreas Thomas, Medtronic GmbH, and Araceli Ramírez and Alfred Zehe, Universidad Autónoma de Puebla